213 related articles for article (PubMed ID: 16787183)
21. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
22. ssDNA-dependent colocalization of adeno-associated virus Rep and herpes simplex virus ICP8 in nuclear replication domains.
Heilbronn R; Engstler M; Weger S; Krahn A; Schetter C; Boshart M
Nucleic Acids Res; 2003 Nov; 31(21):6206-13. PubMed ID: 14576307
[TBL] [Abstract][Full Text] [Related]
23. Four-dimensional visualization of the simultaneous activity of alternative adeno-associated virus replication origins.
Glauser DL; Saydam O; Balsiger NA; Heid I; Linden RM; Ackermann M; Fraefel C
J Virol; 2005 Oct; 79(19):12218-30. PubMed ID: 16160148
[TBL] [Abstract][Full Text] [Related]
24. Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination.
Satoh W; Hirai Y; Tamayose K; Shimada T
J Virol; 2000 Nov; 74(22):10631-8. PubMed ID: 11044107
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration.
Zhang C; Cortez NG; Berns KI
Hum Gene Ther; 2007 Sep; 18(9):787-97. PubMed ID: 17760515
[TBL] [Abstract][Full Text] [Related]
26. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.
Recchia A; Parks RJ; Lamartina S; Toniatti C; Pieroni L; Palombo F; Ciliberto G; Graham FL; Cortese R; La Monica N; Colloca S
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2615-20. PubMed ID: 10077559
[TBL] [Abstract][Full Text] [Related]
27. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
28. High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.
Zhang X; De Alwis M; Hart SL; Fitzke FW; Inglis SC; Boursnell ME; Levinsky RJ; Kinnon C; Ali RR; Thrasher AJ
Hum Gene Ther; 1999 Oct; 10(15):2527-37. PubMed ID: 10543617
[TBL] [Abstract][Full Text] [Related]
29. HSV amplicon vectors for cancer therapy.
Shah K; Breakefield XO
Curr Gene Ther; 2006 Jun; 6(3):361-70. PubMed ID: 16787187
[TBL] [Abstract][Full Text] [Related]
30. Sequence elements of the adeno-associated virus rep gene required for suppression of herpes-simplex-virus-induced DNA amplification.
Kleinschmidt JA; Möhler M; Weindler FW; Heilbronn R
Virology; 1995 Jan; 206(1):254-62. PubMed ID: 7831779
[TBL] [Abstract][Full Text] [Related]
31. The history of the HSV amplicon: from naturally occurring defective genomes to engineered amplicon vectors.
Frenkel N
Curr Gene Ther; 2006 Jun; 6(3):277-301. PubMed ID: 16787181
[TBL] [Abstract][Full Text] [Related]
32. Definition of herpes simplex virus helper functions for the replication of adeno-associated virus type 5.
Stutika C; Hüser D; Weger S; Rutz N; Heßler M; Heilbronn R
J Gen Virol; 2015 Apr; 96(Pt 4):840-850. PubMed ID: 25535322
[TBL] [Abstract][Full Text] [Related]
33. Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
Yan Z; Zak R; Zhang Y; Engelhardt JF
J Virol; 2005 Jan; 79(1):364-79. PubMed ID: 15596830
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
35. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
36. Herpes Simplex Virus 1 Coinfection Modifies Adeno-associated Virus Genome End Recombination.
Meier AF; Tobler K; Michaelsen K; Vogt B; Henckaerts E; Fraefel C
J Virol; 2021 Jun; 95(13):e0048621. PubMed ID: 33853961
[TBL] [Abstract][Full Text] [Related]
37. Development of animal models for adeno-associated virus site-specific integration.
Rizzuto G; Gorgoni B; Cappelletti M; Lazzaro D; Gloaguen I; Poli V; Sgura A; Cimini D; Ciliberto G; Cortese R; Fattori E; La Monica N
J Virol; 1999 Mar; 73(3):2517-26. PubMed ID: 9971837
[TBL] [Abstract][Full Text] [Related]
38. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
39. A 16bp Rep binding element is sufficient for mediating Rep-dependent integration into AAVS1.
Feng D; Chen J; Yue Y; Zhu H; Xue J; Jia WW
J Mol Biol; 2006 Apr; 358(1):38-45. PubMed ID: 16516232
[TBL] [Abstract][Full Text] [Related]
40. A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.
Wang H; Lieber A
J Virol; 2006 Dec; 80(23):11699-709. PubMed ID: 16987973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
